[go: up one dir, main page]

DK3845215T3 - Orale opløsninger omfattende lisdexamfetaminsalte - Google Patents

Orale opløsninger omfattende lisdexamfetaminsalte Download PDF

Info

Publication number
DK3845215T3
DK3845215T3 DK19386059.0T DK19386059T DK3845215T3 DK 3845215 T3 DK3845215 T3 DK 3845215T3 DK 19386059 T DK19386059 T DK 19386059T DK 3845215 T3 DK3845215 T3 DK 3845215T3
Authority
DK
Denmark
Prior art keywords
lisdexamphetamine
salts
oral solutions
solutions including
oral
Prior art date
Application number
DK19386059.0T
Other languages
English (en)
Inventor
Georgios Liolios
Ioannis Psarrakis
Original Assignee
Labomed Pharmaceutical Company S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69190593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3845215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Labomed Pharmaceutical Company S A filed Critical Labomed Pharmaceutical Company S A
Application granted granted Critical
Publication of DK3845215T3 publication Critical patent/DK3845215T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK19386059.0T 2019-12-30 2019-12-30 Orale opløsninger omfattende lisdexamfetaminsalte DK3845215T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19386059.0A EP3845215B1 (en) 2019-12-30 2019-12-30 Oral solutions comprising lisdexamfetamine salts

Publications (1)

Publication Number Publication Date
DK3845215T3 true DK3845215T3 (da) 2022-10-10

Family

ID=69190593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19386059.0T DK3845215T3 (da) 2019-12-30 2019-12-30 Orale opløsninger omfattende lisdexamfetaminsalte

Country Status (17)

Country Link
US (3) US11576878B2 (da)
EP (2) EP3845215B1 (da)
AU (1) AU2020416052A1 (da)
BR (1) BR112022012986A2 (da)
CA (1) CA3165248A1 (da)
CL (1) CL2022001792A1 (da)
CO (1) CO2022010594A2 (da)
DK (1) DK3845215T3 (da)
ES (1) ES2929192T3 (da)
HR (1) HRP20221241T1 (da)
HU (1) HUE059869T2 (da)
IL (1) IL294249B2 (da)
LT (1) LT3845215T (da)
MX (1) MX2022008191A (da)
PL (1) PL3845215T3 (da)
PT (1) PT3845215T (da)
WO (1) WO2021136602A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250064759A1 (en) 2021-12-16 2025-02-27 Labomed Pharmaceutical Company S.A. Container comprising a lisdexamfetamine containing oral solution
BR102022009562A2 (pt) * 2022-05-17 2023-11-28 Ems.S.A. Composição líquida e seu uso, método de tratamento e kit
WO2024003797A1 (en) * 2022-06-30 2024-01-04 Ind-Swift Laboratories Limited Crystalline salts of lisdexamfetamine
EP4561528A1 (en) 2022-07-29 2025-06-04 Labomed Pharmaceutical Company S.A. Lisdexamfetamine containing oral solution
GR1010843B (el) * 2023-10-24 2025-01-09 Pharmaplot Private Compamy, Ποσιμο διαλυμα που περιλαμβανει λισδεξαμφεταμινη και διαδικασια παρασκευης αυτου

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105486B2 (en) 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
WO2006121552A2 (en) 2005-04-08 2006-11-16 New River Pharmaceuticals Inc. Abuse-resistant amphetamine prodrugs
CA3144719A1 (en) * 2019-07-19 2021-01-28 Cheer Global Limited Hemoglobin-based therapeutic agents

Also Published As

Publication number Publication date
US11576878B2 (en) 2023-02-14
LT3845215T (lt) 2022-11-10
IL294249A (en) 2022-08-01
IL294249B1 (en) 2025-08-01
IL294249B2 (en) 2025-12-01
EP3845215A1 (en) 2021-07-07
WO2021136602A1 (en) 2021-07-08
HRP20221241T1 (hr) 2022-12-09
US20230201142A1 (en) 2023-06-29
US20240390304A1 (en) 2024-11-28
US12433859B2 (en) 2025-10-07
BR112022012986A2 (pt) 2022-09-13
CA3165248A1 (en) 2021-07-08
PL3845215T3 (pl) 2022-11-21
US20210401781A1 (en) 2021-12-30
EP4098248A1 (en) 2022-12-07
HUE059869T2 (hu) 2023-01-28
CO2022010594A2 (es) 2022-08-19
AU2020416052A1 (en) 2022-07-14
EP3845215B1 (en) 2022-07-27
CL2022001792A1 (es) 2023-03-03
PT3845215T (pt) 2022-10-17
ES2929192T3 (es) 2022-11-25
MX2022008191A (es) 2022-08-02

Similar Documents

Publication Publication Date Title
DK4072332T3 (da) Fugtige, orale sammensætninger
DK3986890T3 (da) Benzisoxazol-sulfonamid-derivater
DK3845215T3 (da) Orale opløsninger omfattende lisdexamfetaminsalte
IL292161A (en) New methylquinazolinone derivatives
EP3973221C0 (de) Stop & go-molch
EP3423037A4 (en) ORAL ADMINISTRATIVE COMPOSITION
EP3383328C0 (en) ADJUSTABLE ORAL APPLIANCE FOR SLEEP APNEA
PL4013751T3 (pl) Pochodne 2-hydroksycykloalkano-1-karbamoilu
EP3565502A4 (en) Oral irrigator
EP4041122C0 (en) WATER INTERDENTAL CLEANER
EP4077334C0 (en) FUROINDAZOLE DERIVATIVES
EP4021904C0 (en) ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES
DK4072330T3 (da) Orale produkter med reduceret irritation
EP3756471A4 (en) ORAL INGESTION COMPOSITION
EP3920837C0 (en) Oral care appliance
DK3706724T3 (da) Orale rifamycin-sv-sammensætninger
EP3793609C0 (en) ORAL SOLUTION FORMULATION
EP3829551C0 (en) CRYSTALLINE EPINEPHRINE MALONATE SALT
EP4044996C0 (en) ORAL HYGIENE COMPOSITION
EP4268816A4 (en) ORAL SOLID PREPARATION
EP4044995C0 (en) ORAL HYGIENE COMPOSITIONS
EP3950055A4 (en) AQUEOUS FORMULATION
IL311916A (en) Novel trimetazidine salts
EP3634507C0 (en) ORAL EXTENDED DRUG DELIVERY PLATFORMS
EP3874967A4 (en) ORAL COMPOSITION WITH ENHANCED SWEET TASTE